Pharmacologic Characteristics of Indinavir, Didanosine, and Stavudine in Human Immunodeficiency Virus-Infected Children Receiving Combination Therapy
Courtney V. Fletcher(University of Nebraska at Omaha), Mark W. Kline(Tulane University), Dennis R. Weller(University of Minnesota), Rory P. Remmel(University of Minnesota), Nancy R. Calles(Texas Children's Hospital), Richard C. Brundage(MelroseWakefield Healthcare), Cara Simon(Baylor College of Medicine), Linda M. Page(University of Minnesota)
Cited by 69
Related Papers
Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1
|New England Journal of Medicine|1999|211
The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis
|PLoS Medicine|2018|173
The Tingathe programme: a pilot intervention using community health workers to create a continuum of care in the prevention of mother to child transmission of HIV (PMTCT) cascade of services in Malawi
|Journal of the International AIDS Society|2012|145
Primary iris cysts: a review of the literature and report of 62 cases.
|British Journal of Ophthalmology|1984|135